E-mail: service@asclechem.com
Contact Us

Xi'an Asclechem Biotech Co.,LTD

TEL : +86-029-85567924

Fax : +86-029-85567924

E-mail : 


Office Address: 11 1-1-0722, Tang Yanna road 11, Hi tech District Xi’an.

Lab Address: Yuquan Xi Road#16, Xian Yang City. Shaanxi 

Home > News > Content
Strengthen Children's Medicines
Jun 04, 2018

The State administration of drugs and Drug Administration(CFDA) strongly encourages pharmaceutical companies to apply the children’s medicines. And the CFDA will strengthen the evaluation of atypical hemolytic-uremia syndrome, hemophilia, chronic immune thrombocytopenia and other children’s medicines.


As at June 1, the CFDA had issued 28 batches of priority review catalogue, incorporating 520 registration applications into the priority review process, which involved 72 children's medicines.


Next, CFDA will strengthen the regulation of the child medicines instruction.

For details, please contact service@asclechem.com.